Hormone Receptor Positive Breast Carcinoma trials recruiting in California

All Hormone Receptor Positive Breast Carcinoma trials nationally

Cities in California

Recruiting trials in California

• ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
  NCT06224673 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: San Francisco
• Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
  NCT04305834 · Phase: Phase 2 · Ages: 70 Years and older · Sex: All (male and female) · California: Duarte, Irvine, Long Beach, South Pasadena
• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · California: Auburn, Bakersfield, Berkeley, Beverly Hills
• Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
  NCT04553770 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · California: Fullerton, Los Alamitos, Los Angeles, Torrance